Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment.

Gabriella FerrandinaGiulia AmadioAndrea MarcellusiElena AzzoliniAnna PugginaRoberta PastorinoWalter RicciardiGiovanni Scambia

Published in: Clinical drug investigation (2018)

Surgical ovarian ablation is more cost-effective than GnRH administration in the adjuvant treatment of hormone-sensitive breast cancer patients aged 40-49 years, and the advantage of preventing ovarian cancer through laparoscopic BSO should be considered.

Keyphrases

early stage
replacement therapy
smoking cessation